The prevalence of hepatitis C virus infection in the United States Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease, N Engl J Med MMWR Recomm Rep, vol.341, issue.47, pp.556-5621, 1988. ,
Gender Differences in Sexual and Injection Risk Behavior Among Active Young Injection Drug Users in San Francisco (the UFO Study), Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.80, issue.1, pp.137-146, 2003. ,
DOI : 10.1093/jurban/jtg137
Risk of hepatitis C virus transmission through drug preparation equipment: a systematic review, J Viral Hepat, vol.15, pp.279-92, 2008. ,
Frontloading, AIDS, vol.10, issue.3, pp.311-317, 1996. ,
DOI : 10.1097/00002030-199603000-00010
Parenteral Transmission of HIV Among Injection Drug Users: Assessing the Frequency of Multiperson Use of Needles, Syringes, Cookers, Cotton, and Water, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.18, issue.1, pp.18-25, 1998. ,
DOI : 10.1097/00042560-199802001-00006
Sharing of drug preparation equipment as a risk factor for hepatitis C, Am J Public Health, vol.91, pp.42-46, 2001. ,
Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users, Journal of Viral Hepatitis, vol.8, issue.6, pp.560-570, 2006. ,
DOI : 10.1002/jmv.20212
Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users, International Journal of Epidemiology, vol.32, issue.5, pp.715-716, 2003. ,
DOI : 10.1093/ije/dyg169
The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users, International Journal of Epidemiology, vol.32, issue.5, pp.708-714, 2003. ,
DOI : 10.1093/ije/dyg102
Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users, Hepatology, vol.93, issue.3, pp.737-742, 2002. ,
DOI : 10.1053/jhep.2002.35065
Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks, The Journal of Infectious Diseases, vol.186, issue.11, pp.1558-1564, 2002. ,
DOI : 10.1086/345554
Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications, Social Science & Medicine, vol.62, issue.12, pp.3035-3047, 2006. ,
DOI : 10.1016/j.socscimed.2005.11.067
Harm reduction: pragmatic strategies for managing high-risk behaviours, 1998. ,
Ethical Issues in Substance Use Intervention, Substance Use & Misuse, vol.64, issue.1, pp.369-398, 2004. ,
DOI : 10.1081/JA-120029983
Les drogues: approche sociologique, économique et politique Paris: La Documentation Française, 2004. ,
Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done, Public Health Rep, vol.113, issue.1, pp.182-188, 1998. ,
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland, J Clin Microbiol, vol.35, pp.3274-3277, 1997. ,
The Association of Hepatitis C Prevalence, Activity, and Genotype With HIV Infection in a Cohort of New York City Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.33, issue.3, pp.356-364, 2003. ,
DOI : 10.1097/00126334-200307010-00010
Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them, Epidemiology and Infection, vol.135, issue.03, pp.433-442, 2007. ,
DOI : 10.1017/S0950268806007035
Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review, Journal of Viral Hepatitis, vol.30, issue.3, pp.157-173, 2002. ,
DOI : 10.1002/hep.510290442
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, vol.26, issue.10, pp.1499-1508, 2006. ,
DOI : 10.1111/j.1360-0443.2006.01543.x
Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population, Hepatology, vol.11, issue.2, pp.341-351, 2006. ,
DOI : 10.1002/hep.21252
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, Am J Public Health, vol.91, pp.23-30, 2001. ,
Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment, Clinical Infectious Diseases, vol.40, issue.s5, pp.40-330, 2005. ,
DOI : 10.1086/427475
Epidemiology of hepatitis C virus infection among injecting drug users in Australia., Journal of Epidemiology & Community Health, vol.51, issue.6, pp.692-697, 1997. ,
DOI : 10.1136/jech.51.6.692
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression, BMC Infectious Diseases, vol.38, issue.4, p.145, 2007. ,
DOI : 10.1016/S0270-9139(03)80154-4
HIV and hepatitis C among injecting drug users, BMJ, vol.317, issue.7156, pp.424-425, 1998. ,
DOI : 10.1136/bmj.317.7156.424
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not, Med J Aust, vol.170, pp.220-221, 1999. ,
Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City, American Journal of Epidemiology, vol.157, issue.5, pp.467-471, 2003. ,
DOI : 10.1093/aje/kwf222
Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003, Addiction, vol.91, issue.11, pp.1690-1700, 1996. ,
DOI : 10.1111/j.1360-0443.2005.01271.x
Hepatitis C Incidence--a Comparison Between Injection and Noninjection Drug Users in New York City, Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.81, issue.1, pp.20-24, 2004. ,
DOI : 10.1093/jurban/jth084
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study, BMJ, vol.330, issue.7481, pp.24-25, 2005. ,
DOI : 10.1136/bmj.38286.841227.7C
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001, International Journal of Epidemiology, vol.32, issue.5, pp.717-724, 2001. ,
DOI : 10.1093/ije/dyg101
Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough, AIDS, vol.21, issue.14, pp.1967-1969, 2007. ,
DOI : 10.1097/QAD.0b013e3282ef7701
Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data???The ANRS-Coquelicot Study, Substance Use & Misuse, vol.32, issue.1, pp.1603-1621, 2006. ,
DOI : 10.3109/16066359509005236
The HCV Synthesis Project: Scope, methodology, and preliminary results, BMC Medical Research Methodology, vol.316, issue.Suppl 1, p.62, 2008. ,
DOI : 10.1136/bmj.316.7125.140
Global estimates of prevalence of HCV infection among injecting drug users, International Journal of Drug Policy, vol.18, issue.5, pp.352-358, 2007. ,
DOI : 10.1016/j.drugpo.2007.04.004
Phénomènes émergents liés aux drogues en Sixième rapport national du dispositif TREND. OFDT. Saint-Denis, 2004. ,
Les toxicomanes suivis dans les structures sanitaires et sociales en novembre 1996, Etudes et Résultats, vol.1, pp.1-6, 1998. ,
Etude multicentrique sur les attitudes et les comportements des toxicomanes face aux risques de contamination par le VIH et les virus de l'hépatite. IREP, 1996. ,
Les usagers de drogues illicites pris en charge par le système de soins en novembre 1997, Etudes et Résultats, vol.59, pp.1-8, 2000. ,
Sampling and weighting a survey of homeless persons: a French example, Survey Methodology, vol.27, pp.109-118, 2001. ,
Review of sampling hard-to-reach and hidden populations for HIV surveillance, AIDS, vol.19, issue.Supplement 2, pp.67-72 ,
DOI : 10.1097/01.aids.0000172879.20628.e1
A short questionnaire (IRQ) to assess injecting risk behaviour, Addiction, vol.93, issue.3, pp.337-347, 1998. ,
DOI : 10.1046/j.1360-0443.1998.9333373.x
Monitoring the Dynamics of the HIV Epidemic Using Assays for Recent Infection and Serotyping among New HIV Diagnoses: Experience after 2 Years in France, The Journal of Infectious Diseases, vol.196, issue.3, pp.377-383, 2007. ,
DOI : 10.1086/519387
Sciences sociales et épidémiologie: des approches méthodologiques qui se complètent, à propos de la question des pratiques à risque chez les usagers de drogues, Bull Epidemiol Hebd, pp.2-3, 2006. ,
Life trajectory and risk-taking among women drug users, Med Sci, issue.2, pp.111-121, 2008. ,
Lack of Behavior Change after Disclosure of Hepatitis C Virus Infection among Young Injection Drug Users in Baltimore, Maryland, Clinical Infectious Diseases, vol.35, issue.7, pp.783-788, 2002. ,
DOI : 10.1086/342063
Social Circumstances of Initiation of Injection Drug Use and Early Shooting Gallery Attendance: Implications for HIV Intervention Among Adolescent and Young Adult Injection Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.32, issue.1, pp.86-93, 2003. ,
DOI : 10.1097/00126334-200301010-00013
Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users, Ann Med Interne, vol.153, pp.219-225, 2002. ,
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses., American Journal of Public Health, vol.86, issue.5, pp.655-661, 1996. ,
DOI : 10.2105/AJPH.86.5.655
Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users, Drug and Alcohol Dependence, vol.77, issue.3, pp.303-309, 2005. ,
DOI : 10.1016/j.drugalcdep.2004.08.021
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales, BMC Infectious Diseases, vol.330, issue.1, p.93, 2006. ,
DOI : 10.1136/bmj.38286.841227.7C
Individual and Couple???Level Risk Factors for Hepatitis C Infection among Heterosexual Drug Users: A Multilevel Dyadic Analysis, The Journal of Infectious Diseases, vol.195, issue.11, pp.1572-1581, 2007. ,
DOI : 10.1086/516785
Risk factors for hepatitis C virus infection among street youths, CMAJ, vol.165, pp.557-560, 2001. ,
Unstable Housing as a Factor for Increased Injection Risk Behavior at US Syringe Exchange Programs, AIDS and Behavior, vol.27, issue.1, pp.78-84, 2007. ,
DOI : 10.1007/s10461-007-9227-6
Single-room occupancy hotels: possible solutions and alternatives, Body Posit, vol.11, pp.35-39, 1998. ,
HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample, JAMA: The Journal of the American Medical Association, vol.272, issue.6, pp.455-461, 1994. ,
DOI : 10.1001/jama.272.6.455
A Potential Hidden Source of Hepatitis C Infection Among Noninjecting Drug Users, Journal of Psychoactive Drugs, vol.24, issue.4, pp.455-460, 2003. ,
DOI : 10.1186/1471-2334-1-8
Sexual and Other Noninjection Risks for HBV and HCV Seroconversions among Noninjecting Heroin Users, The Journal of Infectious Diseases, vol.195, issue.7, pp.1052-1061, 2007. ,
DOI : 10.1086/512081
Crack Cocaine Smoking and Oral Sores in Three Inner-City Neighborhoods, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.13, issue.1, pp.87-92, 1996. ,
DOI : 10.1097/00042560-199609000-00012
Des Jarlais DC: HIV/hepatitis C virus coinfection in drug users: risk behavior and prevention, AIDS 2005, vol.19, pp.199-207 ,
Crack users' cracked lips: an additional HIV risk factor., American Journal of Public Health, vol.83, issue.10, pp.1490-1491, 1993. ,
DOI : 10.2105/AJPH.83.10.1490-a
Factors associated with HIV/AIDS high-risk behaviours among female injection drug users, AIDS Care, vol.161, issue.1, pp.67-74, 2007. ,
DOI : 10.1016/0149-7189(94)90035-3
Substance use and risky sexual behavior for exposure to HIV: Issues in methodology, interpretation, and prevention., American Psychologist, vol.48, issue.10, pp.1035-1045, 1993. ,
DOI : 10.1037/0003-066X.48.10.1035
Gendered power dynamics and HIV risk in drug-using sexual relationships, AIDS Care, vol.12, issue.4, pp.505-515, 2000. ,
DOI : 10.1080/09540120050123909
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver, CMAJ, vol.166, pp.894-899, 2002. ,
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users, European Journal of Epidemiology, vol.40, issue.Suppl 5, pp.183-193, 2007. ,
DOI : 10.1007/s10654-006-9089-7
Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France, Epidemiology and Infection, vol.132, issue.4, pp.699-708, 2004. ,
DOI : 10.1017/S095026880400247X
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990???2001, AIDS, vol.19, issue.Suppl 3, pp.20-25, 1990. ,
DOI : 10.1097/01.aids.0000192066.86410.8c
A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users, Harm Reduction Journal, vol.3, issue.1, p.27, 2006. ,
DOI : 10.1186/1477-7517-3-27
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users, Addiction, vol.361, issue.9, pp.1454-1462, 2007. ,
DOI : 10.1111/j.1360-0443.2007.01912.x